Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision.

Breast Carcinoma in Situ Carcinoma, Intraductal, Noninfiltrating Nomograms Prognosis

Journal

Journal of breast cancer
ISSN: 1738-6756
Titre abrégé: J Breast Cancer
Pays: Korea (South)
ID NLM: 101314183

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 23 09 2021
revised: 06 11 2021
accepted: 02 02 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 2 2022
Statut: ppublish

Résumé

This study identified factors predicting malignant upgrade for atypical ductal hyperplasia (ADH) diagnosed on core-needle biopsy (CNB) and developed a nomogram to facilitate evidence-based decision making. This retrospective analysis included women diagnosed with ADH at the National Cancer Centre Singapore (NCCS) in 2010-2015. Cox proportional hazards regression was used to identify clinical, radiological, and histological factors associated with malignant upgrade. A nomogram was constructed using variables with the strongest associations in multivariate analysis. Multivariable logistic regression coefficients were used to estimate the predicted probability of upgrade for each factor combination. Between 2010 and 2015, 238,122 women underwent mammographic screening under the National Breast Cancer Screening Program. Among 29,564 women recalled, 5,971 CNBs were performed. Of these, 2,876 underwent CNBs at NCCS, with 88 patients (90 lesions) diagnosed with ADH and 26 lesions upgraded to breast malignancy on excision biopsy. In univariate analysis, factors associated with malignant upgrade were the presence of a mass on ultrasound ( Our model provided good discrimination of breast cancer risk prediction (C-statistic of 0.81; 95% CI, 0.74-0.88) and selected for a subset of women at low risk (2.1%) of malignant upgrade, who may avoid surgical excision following a CNB diagnosis of ADH.

Identifiants

pubmed: 35199500
pii: 25.37
doi: 10.4048/jbc.2022.25.e7
pmc: PMC8876544
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37-48

Informations de copyright

© 2022 Korean Breast Cancer Society.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Hum Pathol. 1992 Oct;23(10):1095-7
pubmed: 1328030
Breast. 2013 Aug;22(4):537-42
pubmed: 23237921
Cancer. 2003 Aug 1;98(3):590-6
pubmed: 12879477
Am J Clin Pathol. 2003 Feb;119(2):248-53
pubmed: 12579995
Menopause. 2007 Sep-Oct;14(5):891-9
pubmed: 17414171
N Engl J Med. 2015 Jan 1;372(1):78-89
pubmed: 25551530
AJR Am J Roentgenol. 2009 Jan;192(1):229-34
pubmed: 19098204
Radiology. 1993 Dec;189(3):667-71
pubmed: 8234688
Mod Pathol. 2003 Feb;16(2):154-60
pubmed: 12591968
Breast Cancer Res Treat. 1993 Nov;28(2):157-66
pubmed: 8173068
Breast. 2011 Apr;20 Suppl 2:S75-80
pubmed: 21316967
Breast. 2007 Apr;16(2):113-9
pubmed: 17081753
Ann Surg Oncol. 2017 Jan;24(1):70-76
pubmed: 27573525
Cancer. 1985 Jun 1;55(11):2698-708
pubmed: 2986821
World J Surg Oncol. 2009 Oct 23;7:77
pubmed: 19852801
Breast Cancer Res. 2006;8(3):R30
pubmed: 16796758
Radiology. 2002 Aug;224(2):548-54
pubmed: 12147855
Pathology. 2002 Oct;34(5):410-6
pubmed: 12408338
Breast Cancer Res Treat. 2017 Jul;164(2):295-304
pubmed: 28474262
Histopathology. 1996 Jun;28(6):537-41
pubmed: 8803597
Am J Surg Pathol. 2001 Aug;25(8):1017-21
pubmed: 11474285
Br J Cancer. 2002 Oct 7;87(8):876-82
pubmed: 12373602
Ann Surg Oncol. 2011 Mar;18(3):752-61
pubmed: 20972636
BMJ. 2014 Feb 11;348:g366
pubmed: 24519768
Ann Epidemiol. 2001 May;11(4):257-63
pubmed: 11306344
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Arch Pathol Lab Med. 2003 Jan;127(1):49-54
pubmed: 12521366

Auteurs

Tiffany Sin Hui Bong (TSH)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.

Jun Kiat Thaddaeus Tan (JKT)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.

Juliana Teng Swan Ho (JTS)

Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore.

Puay Hoon Tan (PH)

Division of Pathology, Singapore General Hospital, Singapore.

Wing Sze Lau (WS)

Department of Clinical Laboratory, Gleneagles Hospital Hong Kong, Hong Kong.

Tuan Meng Tan (TM)

Department of Statistics and Applied Probability, National University of Singapore, Singapore.

Jill Su Lin Wong (JSL)

Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore.

Veronique Kiak Mien Tan (VKM)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Benita Kiat Tee Tan (BKT)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.
Department of General Surgery, Sengkang General Hospital, Singapore.

Preetha Madhukumar (P)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Wei Sean Yong (WS)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Sue Zann Lim (SZ)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Chow Yin Wong (CY)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Kong Wee Ong (KW)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.

Yirong Sim (Y)

Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Department of Breast Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore. sim.yirong@singhealth.com.sg.

Classifications MeSH